Elevated plasminogen activator inhibitor type-1 (PAI-1) as contributing factor in pathogenesis of hypercoagulable state in antiphospholipid syndrome

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Spiros Miyakis, Michael D. Lockshin, Tatsuya Atsumi et al. · Journal of Thrombosis and Haemostasis · 2006 · 7.1K citations · Full text

Medicine, Hematology, Internal Medicine +10

Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients

D Alarcón-Segovia, Margarita Delezé, CARMEN V. ORIA et al. · Medicine · 1989 · 643 citations

Life Sciences, Hematology, Immunology +15

ARTERIAL THROMBOSIS, INTRAUTERINE DEATH AND "LUPUS" ANTICOAGULANT: DETECTION OF IMMUNOGLOBULIN INTERFERING WITH PROSTACYCLIN FORMATION

L Carreras, S.J. Machin, R DEMAN et al. · The Lancet · 1981 · 554 citations

Medicine, Obstetrics, Pathology +16

Pregnancy Loss in the Antiphospholipid-Antibody Syndrome — A Possible Thrombogenic Mechanism

Jacob H. Rand, Xiao-Xuan Wu, Harry A.M. Andree et al. · New England Journal of Medicine · 1997 · 528 citations · Full text

Medicine, Immunology, Obstetrics +17

Elevated fibrinogen and plasminogen activator inhibitor (PAI‐1) in hypertension are related to metabolic risk factors for cardiovascular disease

Lilian Tengborn, Ulf Smith · Journal of Internal Medicine · 1990 · 309 citations

Medicine, Endocrinology, Diabetology +10